Yipurun

Yipurun is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages advanced structure-based drug design (SBDD) and computational chemistry platforms to target challenging biological pathways in oncology and metabolic disorders. Yipurun aims to address significant unmet medical needs by developing high-potency, selective drug candidates with optimized pharmacological profiles. Currently, the company's portfolio is primarily in the discovery and pre-clinical stages, supported by a team of experts in medicinal chemistry and structural biology.